89353-92-4 Usage
General Description
"(4Z,6S,7R)-7-bromo-4,6,8-trichloro-2,6-dimethylocta-1,4-dien-3-one" is a compound with a complex molecular structure consisting of a bromine atom, three chlorine atoms, and multiple methyl groups attached to a carbon backbone. The unique arrangement of atoms and functional groups in this compound gives it specific chemical and biological properties, potentially making it useful in the synthesis of other organic compounds or as a starting material for pharmaceutical research. The presence of bromine and chlorine atoms suggests potential reactivity in organic synthesis, while the methyl groups may contribute to the compound's solubility and physical properties. Overall, "(4Z,6S,7R)-7-bromo-4,6,8-trichloro-2,6-dimethylocta-1,4-dien-3-one" is a complex and potentially versatile chemical compound with diverse potential applications in the field of chemistry and pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 89353-92-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,3,5 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 89353-92:
(7*8)+(6*9)+(5*3)+(4*5)+(3*3)+(2*9)+(1*2)=174
174 % 10 = 4
So 89353-92-4 is a valid CAS Registry Number.
89353-92-4Relevant articles and documents
Highly Selective Synthesis of Halomon, Plocamenone, and Isoplocamenone
Bucher, Cyril,Deans, Richard M.,Burns, Noah Z.
, p. 12784 - 12787 (2015)
Over 160 chiral vicinal bromochlorinated natural products have been identified; however, a lack of synthetic methods for the selective incorporation of halogens into organic molecules has hindered their synthesis. Here we disclose the first total synthesis and structural confirmation of isoplocamenone and plocamenone, as well as the first selective and scalable synthesis of the preclinical anticancer natural product halomon. The synthesis of these inter-halogenated compounds has been enabled by our recently developed chemo-, regio-, and enantioselective dihalogenation reaction.